Publications

Papers in international journals

2024

  • Říhová K, Lapčík P, Veselá B, Knopfová L, Potěšil D, Pokludová J, Šmarda J, Matalová E, Bouchal P, Beneš P. Caspase-9 is a positive regulator of osteoblastic cell migration indentified by diaPASEF Proteomics. J Proteome Res 2024. https://doi.org/10.1021/acs.jproteome.3c00641

2023

  • van Gogh M, Glaus Garzon JF, Sahin D, Knopfova L, Benes P, Boyman O, Jurisica I, Borsig L.Tumor cell-intrinsic c-Myb upregulation stimulates antitumor immunity in a murine colorectal cancer model. Cancer Immunol Res 2023. https://doi.org/10.1158/2326-6066.CIR-22-0912
  • Varadinkova S, Oralova V, Clarke M, Frampton J, Knopfova L, Lesot H, Bartos P. Matalova E. Expression dynamics of metalloproteinases during mandibular bone formation: association with Myb transcription factor. Front. Cell. Dev. Biol. 2023. https://doi.org/10.3389/fcell.2023.1168866
  • Lapcik P, Vesela B, Potesil D, Dadakova K, Zapletalova M, Benes P, Bouchal P, Matalova E. DiaPasef proteotype analysis indicates changes in cell growth and metabolic switch induced by caspase-9 inhibition in chondrogenic cells. Proteomics 2023. doi.org/10.1002/pmic.202200408

2022

  • Stiborek M, Jindříchová L, Meliorosová S, Bednařík A, Prysiazhnyi V, Kroupa J, Houška P, Adamová B, Navrátilová J, Kanický V, Preisler J. Infrared Laser Desorption on Intact Nanoparticles for Digital Tissue Imaging. Anal Chem. 2022. doi.org/10.1021/acs.analchem.2c05216
  • Adamová B, Říhová B, Pokludová J, Beneš P, Šmarda J, Navrátilová J. Synergistic cytotoxicity of perifosine and ABT-737 to colon cancer cells. J Cell Mol Med.  2022. doi.org/10.1111/jcmm.17636
  • Hendrych M, Říhová K, Adamová B, Hradil V, Stiborek M, Vlček P, Hermanová M, Vašíčková J, Beneš P, Šmarda J, Kanický V, Preisler J, Navrátilová J. Disulfriam increases the efficiency of 5-fluorouracil in organotypic cultures of colorectal carcinoma. Biomedicine & Pharmacotherapy. 2022;153:113465. doi.org/10.1016/j.biopha.2022.113465
  • Lenárt S, Lenárt P, Knopfová L, Kotasová H, Pelková V, Sedláková V, Vacek O, Pokludová J, Čan V, Šmarda J, Souček K, Hampl A, Beneš P. TACSTD2 upregulation is an early reaction to lung infection. Sci Rep. 2022;12:9583. doi.org/10.1038/s41598-022-13637-9
  • Koktavá M, Valášek J, Bezdeková D, Prysiazhnyi V, Adamová B, Beneš P, Navrátilová J, Hendrych M, Vlček P, Preisler J, Bednařík A. Metal Oxide Laser Ionization Mass Spectrometry Imaging of Fatty Acids and Their Double Bond Positional Isomers. Anal Chem. 2022;94:8928-8936. doi.org/10.1021/acs.analchem.2c00551
  • Vesela B, Killinger M, Rihova K, Benes P, Svandová E, Kratochvilová A, Trcka F, Kleparnik K, Matalova E. Caspase-8 Deficient Osteoblastic Cells Display Alterations in Non-Apoptotic Pathways. Front Cell Dev Biol. 2022;10:794407. doi.org/10.3389/fcell.2022.794407
  • Říhová K, Dúcka M, Zambo IS, Vymětalová L, Šrámek M, Trčka F, Verner J, Drápela S, Fedr R, Suchánková T, Pavlatovská B, Ondroušková E, Kubelková I, Zapletalová D, Tuček Š, Múdry P, Krákorová DA, Knopfová L, Šmarda J, Souček K, Borsig L, Beneš P. Transcription factor c-Myb: novel prognostic factor in osteosarcoma. Clin Exp Metastasis. 2022;39:375-390. doi.org/10.1007/s10585-021-10145-4

2021

  • Dúcka M, Kučeríková M, Trčka F, Červinka J, Biglieri E, Šmarda J, Borsig L, Beneš P, Knopfová L. c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells. Neoplasia. 2021;23:326-336. doi.org/10.1016/j.neo.2021.01.002
  • Doffe F, Carbonnier V, Tissier M, Leroy B, Martins I, Mattsson JSM, Micke P, Pavlova S, Pospisilova S, Smardova J, Joerger AC, Wiman KG, Kroemer G, Soussi T. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death Differ. 2021; 28: 1477-1492. doi.org/10.1038/s41418-020-00672-0

2020

  • Lenárt S, Lenárt P, Šmarda J, Remšík J, Souček K, Beneš P. Trop2: Jack of ALL Trades, Master of None. Cancers 2020; 11: E3328. doi.org/10.3390/cancers12113328
  • Pavlatovská B, Machálková M, Brisudová P, Pruška A, Štěpka K, Michálek J, Nečasová T, Beneš P, Šmarda J, Preisler J, Kozubek M, Navrátilová J. Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis. Front Oncol. 2020; 10: 581365. doi.org/10.3389/fonc.2020.581365
  • Doffe F, Carbonnier V, Tissier M, Leroy B, Martins I, Mattsson JSM, Micke P, Pavlova S, Pospisilova S, Smardova J, Joerger AC, Wiman KG, Kroemer G, Soussi T. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death Differ. 2020. doi.org/10.1038/s41418-020-00672-0
  • Vesela B, Kratochvilova A, Svandova E, Benes P, Rihova K, Poliard A, Matalova E. Caspase-12 Is Present During Craniofacial Development and Participates in Regulation of Osteogenic Markers. Front Cell Dev Biol. 2020; 8:589136. doi.org/10.3389/fcell.2020.589136
  • Kratochvílová A, Veselá B, Ledvina V, Švandová E, Klepárník K, Dadáková K, Beneš P, Matalová E. Osteogenic impact of pro-apoptotic caspase inhibitors in MC3T3-E1 cells. Sci Rep. 2020; 10: 7489. doi.org/10.1038/s41598-020-64294-9
  • Bendarik A, Preisler J, Bezdekova D, Machalkova M, Hendrych M, Navratilova J, Knopfova L, Moskovets E, Soltwisch J, Dreisewerd K. Ozonization of Tissue Sections for MALDI MS Imaging of Carbon-Carbon Double Bond Positional Isomers of Phospholipids. Anal Chem 2020: doi.org/10.1021/acs.analchem.0c00641

2019

  • Roblek M, Protsyuk D, Becker PF, Stefanescu C, Gorzelanny C, Glaus Garzon JF, Knopfova L, Heikenwalder M, Luckow B, Schneider SW, Borsig L. CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis. Mol Cancer Res. 2019: 17, 783-793. 10.1158/1541-7786.MCR-18-0530
  • Faktor J, Knopfova L, Lapcik P, Janacova L, Paralova V, Bouchalova P, Muller P, Benes P, Bouchal P. Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis. Proteomics 2019: 19, e1900073. doi.org/10.1002/pmic.201900073
  • Volodko N, Gutor T, Petronchak O, Huley R, Dúcka M, Šmarda J, Borsig L, Beneš P, Knopfová L. Low infiltration of tumor-associated macrophages in high c-Myb expressing breast tumors. Sci Rep. 2019: 9: 11634. 10.1038/s41598-019-48051-1
  • Průcha J, Skopalik J, Socha V, Hanáková L, Knopfová L, Hána K. Two types of high inductive electromagnetic stimulation and their different effects on endothelial cells. Physiol Res. 2019: 68: 611-622. 10.33549/physiolres.933998
  • Tichý M, Knopfová L, Jarkovský J, Vlček P, Katolická J, Čapov I, Hermanová M, Šmarda J, Beneš P. High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma. J Cancer. 2019: 10: 1393-1397. 10.7150/jca.29530
  • Šimečková Š, Kahounová Z, Fedr R, Remšík J, Slabáková E, Suchánková T, Procházková J, Bouchal J, Kharaishvili G, Král M, Beneš P, Souček K. High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells. Sci Rep. 2019: 9, 5695. 10.1038/s41598-019-42131-y
  • Bednařík A, Machálková M, Moskovets E, Coufalíková K, Krásenský P, Houška P, Kroupa J, Navrátilová J, Šmarda J, Preisler J. MALDI MS Imaging at Acquisition Rates Exceeding 100 Pixels per Second. J Am Soc Mass Spectrom. 2019: 30, 289-298. doi.org/10.1007/s13361-018-2078-8
  • Machálková M, Pavlatovská B, Michálek J, Pruška A, Štěpka K, Nečasová T, Radaszkiewicz KA, Kozubek M, Šmarda J, Preisler J, Navrátilová J. Drug Penetration Analysis in 3D Cell Cultures Usin Fiducal-Based Semiautomatic Coregistration of MALDI MSI and Immunofluorescence Images. Anal Chem. 2019: 91: 13475-13484. doi.org/10.1021/acs.analchem.9b02462
  • Michálek J, Štěpka K, Kozubek M, Navrátilová J, Pavlatovská B, Machálková M, Preisler J, Pruška A. Quantitative Assessment of Anti-Cancer Drug Efficacy From Coregistred Mass Spectrometry and Fluorescence Microscopy Images of Multicellular Tumor Spheroids. Microsc Microanal. 2019: 25: 1311-1322. 10.1017/S1431927619014983

2018

  • Remšík J, Binó L, Kahounová Z, Kharaishvili G, Šimecková Š, Fedr R, Kucírková T, Lenárt S, Muresan XM, Slabáková E, Knopfová L, Bouchal J, Král M, Beneš P, Soucek K. Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition. Carcinogenesis. 2018: 39, 1411-1418. 10.1093/carcin/bgy095
  • Kučírková T, Stiborek M, Dúcka M, Navrátilová J, Bogdanović Pristov J, Popović-Bijelić A, Vojvodić S, Preisler J, Kanický V, Šmarda J, Spasojević I, Beneš P. Anti-cancer effects of wedelolactone: interactions with copper and subcellular localization. Metallomics. 2018; 10: 1524-1531. doi.org/10.1039/C8MT00191J
  • Knopfová L, Biglieri E, Volodko N, Masařík M, Hermanová M, Glaus Garzón JF, Dúcka M, Kučírková T, Souček K, Šmarda J, Beneš P, Borsig L.Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding. Oncogene. 2018; 37: 1020-1030. 10.1038/onc.2017.392
  • Chalásová K, Pácal L, Pleskačová A, Knopfová L, Řehořová J, Tomandlová M, Tomandl J, Kaňková K. Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction. Exp Clin Endocrinol Diabetes. 2018: 126: 255-262. 10.1055/s-0043-115009

2017​

  • Nehybová T, Šmarda J, Daniel L, Stiborek M, Kanický V, Spasojevič I, Preisler J, Damborský J, Beneš P. Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. Int J Mol Sci. 2017; 18:  E729. 10.3390/ijms18040729
  • Kučera J, Netušilová J, Sladeček S, Lánová M, Vašíček O, Štefková K, Navrátilová J, Kubala L, Pacherník J. Hypoxia Downregulates MAPK/ERK but Not STAT3 Signaling in ROS-Dependent and HIF-1-Independent Manners in Mouse Embryonic Stem Cells. Oxid Med Cell Longev. 2017; 2017 :4386947. 10.1155/2017/4386947
  • Oralova V, Matalova E, Killinger M, Knopfova L, Smarda J, Buchtova M. Osteogenic Potential of the Transcription Factor c-MYB. Calcif Tissue Int. 2017: 100, 311-322. 10.1007/s00223-016-0219-2
  • Hofmanová J, Slavík J, Ovesná P, Tylichová Z, Vondráček J, Straková N, Vaculová AH, Ciganek M, Kozubík A, Knopfová L, Šmarda J, Machala M. Dietary fatty acids specifically modulate phospholipid pattern in colon cells with distinct differentiation capacities. Eur J Nutr 2017: 56, 1493-1508. doi.org/10.1007/s00394-016-1196-y
  • Navrátilová J, Karasová M, Kohutková Lánová M, Jiráková L, Budková Z, Pacherník J, Šmarda J, Beneš P. Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate. J Cell Mol Med. 2017: 21, 1859-1869. doi.org/10.1111/jcmm.13106

2016

  • Häuselmann I, Roblek M, Protsyuk D, Huck V, Knopfova L, Grässle S, Bauer AT, Schneider SW, Borsig L. Monocyte Induction of E-Selectin-Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade. Cancer Res. 2016; 76: 5302-12. 10.1158/0008-5472.CAN-16-0784
  • Pekarčíková L, Knopfová L, Beneš P, Šmarda J. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells. Cell Signal. 2016; 28: 924-36. 10.1016/j.cellsig.2016.04.007
  • Zlamalikova L, Moulis M, Salek D, Jarkovsky J, Smarda J, Smardova J. Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas. Oncol Rep. 35: 2673-80, 2016. 10.3892/or.2016.4658
  • Tichý M, Knopfová L, Jarkovský J, Pekarčíková L, Veverková L, Vlček P, Katolická J, Čapov I, Hermanová M, Šmarda J, Beneš P. Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma. Tumour Biol 2016: 37, 10723-10729. 10.1016/j.cellsig.2016.04.007
  • Jancekova B, Ondrouskova E, Knopfova L, Smarda J, Benes P. Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL. Tumour Biol 2016; 37, 10685-10696. 10.1007/s13277-016-4958-5
  • Smardova J, Liskova K, Ravcukova B, Malcikova J, Hausnerova J, Svitakova M, Hrabalkova R, Zlamalikova L, Stano-Kozubik K, Blahakova I, Speldova J, Jarkovsky J, Smarda J. Complex analysis of the p53 tumor suppressor in lung carcinoma. Oncol Rep. 35: 1859-67, 2016. 10.3892/or.2015.4533

2015

  • Švandová E, Veselá B, Šmarda J, Hampl A, Radlanski RJ, Matalová E. Mouse Incisor Stem Cell Niche and Myb Transcription Factors. Anat Histol Embryol 44: 338-344, 2015.
  • Nehybova T, Smarda J, Daniel L, Brezovsky J, Benes P. Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling. J Steroid Biochem Mol Biol. 152: 76-83, 2015.
  • Oralová V, Matalová E, Janečková E, Drobná Krejčí E, Knopfová L, Šnajdr P, Tucker AS, Veselá I, Šmarda J, Buchtová M. Role of c-Myb in chondrogenesis. Bone 76: 97-106, 2015.

2014

  • Veselá, B., Švandová, E., Šmarda, J., Matalová, E. Mybs in mouse hair follicle development. Tissue and Cell 46: 352-355, 2014
  • Skopalik, J., Polakova, K., Havrdova, M., Justan, I., Magro, M., Milde, D., Knopfova, L., Smarda, J., Polakova, H., Gabrielova, E., Vianello, F., Michalek, J., Zboril, R.  Mesenchymal stromal cell labelling by new uncoated supermagnetic maghemite nanoparticles in comparison with commercial Resovist - an initial in vitro study. International Journal of Nanomedicine 9:5355-5372, 2014
  • Nehybová, T., Šmarda, J., Beneš, P. Plant coumestans: Recent Advances and Future Perspectives in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 14: 1351-1362, 2014
  • Leucht K., Fischbeck A., Caj M., Hartlieb E., Beneš P., Fried M., Humpf H.U., Rogler G., Hausmann M. Sphingomyelin and phosphatidylcholine contrarily affect the induction of apoptosis in intestinal epithelial cells. Mol. Nutr. Food Res. 58: 782-798, 2014

2013

  • Trčka F., Šmarda J., Knopfová L., Kuziaková K., Beneš P. Nuclear factor of activated T-cells 1 increases sensitivity of v-myb transformed monoblasts to all-trans retionoic acid. Cell Signal 2013; 25, 1546-1555.
  • Navrátilová J., Hankeová T., Beneš P., Šmarda J. Acidic pH of tumor microenvironment enhances cytotoxicity of disulfiram to breast and colon cancer cells. Chemotherapy 2013; 59, 112-120.
  • Navrátilová J., Hankeová T., Beneš P., Šmarda J. Low-glucose conditions of tumor microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells. Nutr Cancer 2013; 65: 702-710.
  • Smardova J., LIskova K., Ravcukova B., Kubiczkova L., Sevcikova S., Michalek J., Svitakova M., Vybihal V., Kren L., Smarda J. High frequency of temperature-sensitive mutants of p53 in glioblastoma. Pathol. Oncol. Res. 2013; 19: 421-428.

2012

  • Slováčková J., Šmarda J., Šmardová J. Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53. Neoplasma 2012; 59: 606-612.
  • Beneš P., Alexová P., Knopfová L., Španová A., Šmarda J. Redox state alters anti-cancer effects of wedelolactone. Environ Mol Mutagen 2012; 53: 515-524.
  • Lungova V., Buchtova M., Janeckova E., Tucker AS., Knopfova L., Smarda J., Matalova E. Localization of c-Myb in differentiated cells during postnatal molar and alveolar bone development. Eur J Oral Sci 2012, 120(6), 495-504.
  • Jagosova J., Pitrova L., Slovackova J., Ravcukova B., Šmarda J., Smardova J. Transactivation and reactivation capabilities of temperature-dependent p53 mutants in yeast and human cells. Int J Oncol 2012; 41: 1157-1163.
  • Faltejskova P., Besse A., Sevcikova S., Kubiczkova L., Svoboda M., Smarda J., Kiss I., Vyzula R., Slaby O. Clinical correlations of miR-21 in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells. Int J Colorectal Dis 2012; 27: 1401-1408.
  • Knopfova L., Benes P., Pekarcikova L., Hermanova M., Masarik M., Pernicova Z., Soucek K., Smarda J. c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis. Mol Cancer 2012; 11: 15.

2011

  • Beneš P., Knopfová L., Trčka F., Nemajerová A., Pinheiro D., Soucek K., Šmarda J. Inhibition of topoisomerase IIa: novel function of wedelolactone. Cancer Lett. 2011; 303(1): 29-38.
  • Matalova E, Buchtova M, Tucker AS, Bender TP, Janeckova E, Lungova V, Balkova S, Smarda J. Expression and characterization of c-Myb in prenatal odontogenesis. Dev Growth Differ 2011; 53(6): 793-803.

2010

  • Slováčková J, Grochová D, Navrátilová J, Šmarda J, Šmardová J. Transactivation by temperature-dependent p53 mutants in yeast and human cells. Cell Cycle 2010: 9(11), 2141-2148.
  • Jungová P, Navrátilová J, Peš O, Vaculovič T, Kanický V, Šmarda J, Preisler J. Substrate-assisted laser desorption inductively-coupled plasma mass spectrometry for determination of copper in myeloid leukemia cells. Journal of Analytical Atomic Spectrometry 2010: 25, 662-668.
  • Kaňková K, Beneš P, Kuchtičková S. Functional analysis of the common haplotype in the receptor for advanced glycationend-products gene previously identified as a susceptibility factor for diabetic nephropathy. Exp Clin Endocrinol Diabetes 2010: 118, 93-95.

2009

  • Navrátilová J, Jungová P, Vaňhara P, Preisler J, Kanický V, Šmarda J. Copper ions regulate cytotoxicity of disulfiram to myeloid leukemia cells. Int J Mol Med 24(5): 661-670,2009.
  • Vaňhara P, Lincová E, Kozubík A, Jurdic P, Souček K, Šmarda J. Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation. Differentiation 78(4): 213-222, 2009.
  • Ondroušková E, Slováčková J, Pelková V, Procházková J, Souček K, Beneš P, Šmarda J. Heavy metals induce phosphorylation of the Bcl-2 protein by Jun N-terminal kinase. Biol Chem 390(1) :49-58, 2009.

2008

  • Šmardová, J., Grochová, D., Fabian, P., Moulis, M., Smarda, J., Falkova, I., Ravcukova, B., Vankova, J., Vasova, I. An unusual p53 mutation detected in Burkitt´s lymphoma: 30 bp duplication. Oncology Reports 20: 773-778, 2008.
  • Knopfová, L., Šmarda, J. v-Myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of human promonocytic U937 cells. Neoplasma 55 (4): 286-293, 2008.
  • Beneš P, Větvička V, Fusek M. Cathepsin D – Many functions of one aspartic protease. Critical Reviews in Oncology/Hematology 2008: 68, 12-28.
  • Grochová, D., Vaňková, J., Damborský, J., Ravčuková, B., Šmarda, J., Vojtěšek, B., Šmardová, J. Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast.Oncogene 27 (9): 1243-1252, 2008.
  • Ondroušková, E., Souček, K., Horváth, V., Šmarda, J. Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis.Leukemia Research 32 (4): 599-609, 2008.

2007

  • Beneš, P., Macečková, V., Zatloukalová, J., Kovářová, L., Šmardová, J., Šmarda, J. Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid. Leukemia Research 31 (10): 1421-1431, 2007.
  • Navrátilová, J., Horváth, V., Kozubík, A., Lojek, A., Lipsick, J., Šmarda, J. p53 arrests growth and induces differentiation of v-myb-transformed monoblasts. Differentiation 75 (7): 592-604, 2007.
  • Vaňhara, P., Bryja, V., Horváth, V., Kozubík, A., Hampl, A., Šmarda, J. c-Jun induces apoptosis of starved BM2 monoblasts by activating cyclin A-CDK. Biochem. Biophys. Res. Commun. 353: 92-97, 2007.
  • Ondroušková, E., Povolná K., Váňa, P., Beneš, P., Konečná, H., Zdráhal, Z., Šmarda, J. A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts. Leukemia Research 31: 221-229, 2007.

2006

  • Vaňhara, P., Šmarda. Jun: the master regulator in healthy and cancer cells. J. Appl.Biomed. 4: 163-170, 2006.
  • Beneš, P., Macečková, V., Zdráhal, Z., Konečná, H., Zahradníčková, E., Mužík, J., Šmarda, J. Role of vimentin in regulation of monocyte/macrophage differentiation. Differentiation 74 (6): 265-276, 2006.

2005

  • Šmardová, J., Šmarda, J., Koptíková, J. Functional variants of the p53 tumor suppressor. Differentiation 73: 261-277, 2005.
  • Šmardová, J., Nemajerová, A., Navrátilová, J., Jurdic, P., Šmarda, J. CBP sensitizes v-myb-transformed monoblasts to differentiation inducers. Differentiation 73: 222-232, 2005.

2003

  • Zahradníčková, E., Souček, K., Ševčíková, S., Šmardová, J., Šmarda, J. c-Fos but not v-Fos induces programmed death of v-myb-transformed monoblasts. Cell. Mol. Life Sci., 60: 2736-2748, 2003.
  • Bryja, V., Sedláček, J., Zahradníčková, E., Ševčíková S., Pacherník, J., Souček, K., Hofmanová, J., Kozubík, A., Šmarda, J. Lipoxygenase inhibitors enhance tumor suppressive effects of Jun proteins on v-myb-transformed monoblasts BM2. Prostaglandins and Other Lipid Mediators, 72 (3-4): 131-145, 2003.
  • Nemajerová, A., Šmarda, J., Jurdic, P., Kubala, L., Souček, K., Šmardová, J.Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. Journal of Hematotherapy and Stem Cell Research, 12 (2): 225-236, 2003

2002

  • Ševčíková, S., Souček, K., Kubala, L., Bryja, V., Šmarda, J. Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts. Cell. Mol. Life Sci. 59 (10): 1690-1705, 2002.
  • Kizek, R., Trnková, L., Ševčíková, S., Šmarda, J., Jelen, F. Silver electrode as a sensor for determination of zinc in cell cultivation medium. Anal. Biochem. 301: 8-13, 2002.
  • Fialová, M., Ševčíková, S., Šmarda, J., Michálek, J. Determination of optimal conditions for acute myeloid leukemia t(18;21) and t(15;17) translocations using RT-PCR. Neoplasma 49: 33-37, 2002.

2000

  • Vodička, P., Ševčíková, S., Šmardová, J., Souček, K., Šmarda, J. The effects of RAR and RXR proteins on growth, viability and differentiation of v-myb-transformed monoblasts. Blood Cells, Molecules and Diseases 26 (4): 395-406, 2000.

1999

  • Šmarda, J., Zemanová, K., Bryja, J., Šmardová, J., Kozubík, A., Hofmanová, J.,Nemajerová, A., Ševčíková, S., Kohoutek, J., Vodička, P. Retinoid X receptor suppresses transformation by the v-myb oncogene. J. Leuk. Biol. 66: 1039-1048, 1999.

1998

  • Zemanová, K., Šmarda, J. Oncoprotein v-Myb and retinoic acid receptor are mutual antagonists. Blood Cells, Molecules and Diseases 24 (11): 239-250, 1998.

1995

  • Engelke, U., Šmarda, J., Lipsick, J. By-pass of TPA-induced differentiation and cell cycle arrest by the c-Myb DNA-binding domain. Oncogene 11: 735-741, 1995.
  • Šmarda, J., Lipsick, J. Retinoic acid receptor alpha represses transformation by v-myb. Physics, Chemistry and Application of Molecular Systems: 35-40, 1995.
  • Šmarda, J., Sugarman, J., Glass, C., Lipsick, J. Retinoic acid receptor suppresses transformation by v-myb. Mol. Cell. Biol. 15: 2474-2481, 1995.

1994

  • Šmarda, J., Lipsick, J. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene 9: 237-245, 1994.
Papers in Czech journals
  • Pekarčíková, L., Knopfová, L., Ondroušková, E., Šmarda J.
    Využití průtokové cytometrie pro analýzu mitochondriální buněčné smrti
    Klin Onkol 2014; Suppl 1:S15-21
  • Knopfová, L., Bouchal, P., Šmarda, J.
    Metody studia buněčné migrace a invazivity nádorových buněk
    Klin Onkol 2014; Suppl 1:S28-33
  • Vaňhara, P., Šmarda, J.
    Regulace aktivity osteoklastů: prostor pro terapii některých onemocnění kostí.
    Časopis lékařů českých 145 (8): 606-610, 2006.
  • Šmardová, J., Šmarda, J.
    Molekulární podstata vzniku nádorů.
    Universitas, 4: 29-37, 2005
  • Knopfová, L., Šmarda, J.
    Cílené zásahy do genové exprese.
    Biologické listy 70 (4): 249-270, 2005.
  • Beneš, P., Šmarda J.
    Vimentin: příklad aktivního zapojení složky cytoskeletu do regulačních procesů buňky.
    Biologické listy 69 (4): 265-278, 2004.
  • Váňa, J., Šmarda, J.
    Analýza proteomu leukemické buněčné linie BM2: optimalizace přípravy vzorku pro dvourozměrnou elektroforézu.
    Chemické listy 98: 1130-1134, 2004.
  • Šmardová, J., Šmarda, J., Koptíková, J.
    Funkční varianty nádorového supresoru p53.
    Biologické listy 69 (3): 191-214, 2004.
  • Zahradníčková, E., Šmarda, J.
    Proteiny Fos: struktura, regulace a úloha v buňce.
    Biologické listy 68 (4): 301-312, 2003.
  • Šmardová, J., Šmarda, J.
    Buněčná linie BM2: model pro studium krvetvorby a leukemogeneze.
    Biologické listy 67 (4): 245-252, 2002.
  • Šmardová, J., Šmarda, J.
    Důsledky vrozených a somatických mutací genů, jejichž produkty se účastní přestavby chromatinu.
    Časopis lékařů českých 141 (4): 112-117, 2002.
  • Šmarda, J.
    Onkogen v-myb a možnosti jeho suprese.
    Scripta Medica (Brno) 74 (2): 125-126, 2001.
  • Šmardová, J., Šmarda, J.
    Mechanismy přestavby chromatinu.
    Biologické listy 66 (4): 283-303, 2001.
  • Šmarda, J., Fialová M., Šmarda, J.
    Jr.Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts.
    Folia Biologica (Praha) 47: 11-13, 2001.
  • Michálek, J., Šmarda, J.
    Detection of minimal residual disease in acute myeloid leukemia.
    Scripta Medica (Brno) 73 (4): 223-228, 2000.
  • Šmarda, J.
    Structure and function of erythropoietin. A review.
    Scripta Facultatis Scientiarum Naturalium Universitatis Masarykianae Brunensis Vol. 26 (Biology): 27-32, 2000.
  • Šmardová, J., Šmarda, J.
    Klinické důsledky mutací genu CBP.
    Časopis lékařů českých 138 (24): 739-743, 1999.
  • Michálek, J., Šmarda, J., Ševčíková, S., Hrstková, H.
    Nejčastější chromozomální přestavby u dětí s akutní myeloidní leukemií a možnosti jejich sledování na molekulární úrovni.
    Klinická onkologie 12: 191-195, 1999.
  • Zemanová, K., Šmarda, J.
    A possible cross-talk of retinoic acid- and TPA-driven differentiation pathways.
    Folia Biologica 44: 97-106, 1998.
  • Šmarda, J.
    Receptory pro retinoidy.
    Biologické listy 61: 1-11, 1996.
  • Petrová K., Hermanová, P., Šmarda, J.
    Inhibition of retinoic acid receptor-alpha results in growth arrest of v-myb-transformed monoblasts.
    Scripta Medica (Brno) 68: 195-206, 1995.

Organizational structure:
Masaryk UniversityFaculty of ScienceDepartment of Experimental BiologySection of Genetics and Molecular BiologyLaboratory of Cell Differentiation

You are running an old browser version. We recommend updating your browser to its latest version.

More info